Palisade BioPALI
13F holders, Q3 2024 (September 30)9holders +1
1new positions
0sold out
$3.55avg. 13F price*
At the end of Q3 2024, 9 institutions reported holding Palisade Bio Inc. (PALI) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($185K), Marex Group Ltd ($127K) and JPMorgan Chase & Co. ($29K).
- Company
- Palisade Bio Inc.
- CUSIP
- 696389402
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $29K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 33,205 shares bought and 1,185 shares sold, net +32,020 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Armistice Capital, LLC | 0.00% | Add +86.7% | 52,000 | $185K |
| Marex Group Ltd | 0.00% | No change | 35,759 | $127K |
| JPMorgan Chase & Co. | 0.00% | New | 8,200 | $29K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +116.4% | 1,597 | $6K |
| Morgan Stanley | 0.00% | No change | 140 | $497 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 100 | $355 |
| UBS Group AG | 0.00% | Reduce -97.5% | 31 | $110 |
| Wells Fargo & Company | 0.00% | No change | 21 | $75 |
| Bank of America Corp. | 0.00% | Add +80.0% | 9 | $32 |
"% of holder's portfolio" is PALI's weight in each manager's 13F, not the share of Palisade Bio Inc. the manager owns.